| Target- | 
| Mechanism- | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.China | 
| First Approval Date29 Apr 2019 | 
100 Clinical Results associated with Guangdong Baiyi Pharmaceutical Co. Ltd.
0  Patents (Medical) associated with Guangdong Baiyi Pharmaceutical Co. Ltd.
100 Deals associated with Guangdong Baiyi Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Guangdong Baiyi Pharmaceutical Co. Ltd.